Review article: the histological assessment of disease activity in ulcerative colitis

Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up

(2015) Robert V Bryant et al.   GUT

Histological inflammation in ulcerative colitis in deep remission under treatment with infliximab

(2015) Antonio Tursi et al.   Clinics and Research in Hepatology and Gastroenterology

Comparing histological activity indexes in UC

(2014) Aude Bressenot et al.   GUT

Histologic Evaluation of Ulcerative Colitis

(2014) Mahmoud H. Mosli et al.   INFLAMMATORY BOWEL DISEASES

Endoscopic biopsy samples of naïve “colitides” patients: Role of basal plasmacytosis

(2014) Vincenzo Villanacci et al.   Journal of Crohns & Colitis

Systematic review: Histological remission in inflammatory bowel disease. Is ‘complete’ remission the new treatment paradigm? An IOIBD initiative

(2014) R.V. Bryant et al.   Journal of Crohns & Colitis

Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis?

(2013) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology

Definition and evaluation of mucosal healing in clinical practice

(2013) Silvia Mazzuoli et al.   DIGESTIVE AND LIVER DISEASE

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

(2013) Simon P L Travis et al.   GUT

Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study

(2013) Lloyd Mayer et al.   GUT

Microscopic Features for Initial Diagnosis and Disease Activity Evaluation in Inflammatory Bowel Disease

(2013) Aude Bressenot et al.   INFLAMMATORY BOWEL DISEASES

Evolving Definitions of Remission in Crohn’s Disease

(2013) Remo Panaccione et al.   INFLAMMATORY BOWEL DISEASES

European consensus on the histopathology of inflammatory bowel disease

(2013) F. Magro et al.   Journal of Crohns & Colitis

Histological healing in inflammatory bowel disease: A still unfulfilled promise

(2013) Vincenzo Villanacci   WORLD JOURNAL OF GASTROENTEROLOGY

Animal Models of Inflammatory Bowel Diseases: Illuminating the Pathogenesis of Colitis, Ileitis and Cancer

(2012) Markus F. Neurath   DIGESTIVE DISEASES

Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study

(2012) William J. Sandborn et al.   GASTROENTEROLOGY

Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD

(2012) Pauliina Molander et al.   Journal of Crohns & Colitis

Review article: defining remission in ulcerative colitis

(2011) S. P. L. Travis et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease

(2011) Laurent Peyrin-Biroulet et al.   Journal of Crohns & Colitis

Biological and histological parameters as predictors of relapse in ulcerative colitis: A prospective study

(2011) Sheenam Azad et al.   Saudi Journal of Gastroenterology

Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis

(2010) F. Hartmann et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial

(2008) W Kruis et al.   GUT